A Novel Proton-Dependent Nucleoside Transporter, CeCNT3, fromCaenorhabditis elegans

  1. Guangqing Xiao,
  2. Juan Wang,
  3. Tonje Tangen and
  4. Kathleen M. Giacomini
  1. Department of Biopharmaceutical Sciences, School of Pharmacy, University of California, San Francisco, San Francisco, California

    Abstract

    In this study, we describe the cloning and characterization of a proton-dependent, broadly selective nucleoside transporter fromCaenorhabditis elegans. Recently, we constructed a broadly selective nucleoside transporter which accepts both purine and pyrimidine nucleosides. Based on these studies, we hypothesized that CNTs with novel substrate selectivities exist in nature and that a CNT homolog in the C. elegans genomic database may function as a broadly selective nucleoside transporter. We cloned the cDNA for this transporter, termed CeCNT3 because of its broad selectivity, using polymerase chain reaction-based methods. CeCNT3 is predicted to have 575 amino acid residues (63.4 kDa) with 11 to 14 putative transmembrane domains and exhibits ∼30% identity to members of the mammalian CNT family. This transporter exhibits a novel substrate selectivity, transporting a wide range of purine and pyrimidine nucleosides (inosine, guanosine, adenosine, uridine, and thymidine) but not cytidine. The apparent Km values for inosine and thymidine are 15.2 ± 5.3 μM and 11.0 ± 2.4 μM, respectively. Kinetic studies demonstrate that purine and pyrimidine nucleosides share a common recognition site in the transporter. In contrast to all known members of the mammalian CNT family, CeCNT3-mediated transport of nucleosides is proton-, but not sodium-, dependent. Mutation of tyrosine 332 in CeCNT3 decreased both the maximum uptake rate and apparent Km of thymidine, suggesting that this residue is in the domain of nucleoside recognition and translocation. The broad nucleoside specificity of CeCNT3 may be explained by this and other residues that restrict purine and pyrimidine nucleoside uptake and that discriminate among pyrimidine nucleosides.

    Footnotes

    • Send reprint requests to: Kathleen M. Giacomini, Ph.D., Department of Biopharmaceutical Sciences, Box 0446, University of California, San Francisco, California. E-mail:kmg{at}itsa.ucsf.edu

    • This study was supported by National Institutes of Health Grant GM42230.

    • Abbreviations:
      CNT
      concentrative nucleoside transporter
      rCNT
      rat concentrative nucleoside transporter
      PCR
      polymerase chain reaction
      MES
      2-(N-morpholino)-ethanesulfonic acid
      bp
      base pair(s)
      TMD
      transmembrane domain
      hCNT
      human concentrative nucleoside transporter
      5′TMP
      thymidine monophosphate
      NBMPR
      nitrobenzylthioinosine
      FCCP
      carbonyl cyanidep-trifluoromethoxyphenylhydrazone
      • Received May 11, 2000.
      • Accepted October 18, 2000.
    « Previous | Next Article »Table of Contents